InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
RLAY
Result 244 decisions over 120 months
Reset filters
Direction ?
Both244 Bought5 Sold239
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: RLAY
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
RLAY Relay Therapeutics, Inc.
14 Apr 2022
Patel Sanjiv
President and CEO
Sold, plan not stated 2×
28,000
$854.28K
9.9%
RLAY Relay Therapeutics, Inc.
13 Apr 2022
Patel Sanjiv
President and CEO
Sold, plan not stated 2×
28,000
$894.60K
9.9%
RLAY Relay Therapeutics, Inc.
12 Apr 2022
Patel Sanjiv
President and CEO
Sold, plan not stated
28,000
$890.40K
9.9%
RLAY Relay Therapeutics, Inc.
1 Apr 2022
Bergstrom Donald A
President, R&D
Sold, plan not stated
18,000
$545.76K
16.0%
RLAY Relay Therapeutics, Inc.
29 Mar 2022
Bergstrom Donald A
President, R&D
Sold, plan not stated
622
$18.58K
0.7%
RLAY Relay Therapeutics, Inc.
29 Mar 2022
Adams Brian
Chief Legal Officer
Sold, plan not stated
333
$9.95K
0.5%
RLAY Relay Therapeutics, Inc.
29 Mar 2022
Porter Andy
Chief Administrative Officer
Sold, plan not stated
294
$8.78K
0.6%
RLAY Relay Therapeutics, Inc.
29 Mar 2022
Catinazzo Thomas
Chief Financial Officer
Sold, plan not stated
282
$8.42K
0.5%
RLAY Relay Therapeutics, Inc.
24 Mar 2022
Catinazzo Thomas
Chief Financial Officer
Sold, plan not stated
13,286
$398.58K
19.7%
RLAY Relay Therapeutics, Inc.
24 Mar 2022
Bergstrom Donald A
President, R&D
Sold, plan not stated
10,000
$300.00K
9.5%
RLAY Relay Therapeutics, Inc.
10 Mar 2022
Bergstrom Donald A
President, R&D
Sold, plan not stated
10,000
$250.00K
9.5%
RLAY Relay Therapeutics, Inc.
1 Mar 2022
Bergstrom Donald A
President, R&D
Sold, plan not stated
8,000
$191.04K
7.8%
RLAY Relay Therapeutics, Inc.
22 Feb 2022
Bergstrom Donald A
President, R&D
Sold, plan not stated 3×
22,994
$481.58K
19.5%
RLAY Relay Therapeutics, Inc.
27 Dec 2021
Bergstrom Donald A
See Remarks
Sold, plan not stated
649
$21.48K
1.4%
RLAY Relay Therapeutics, Inc.
27 Dec 2021
Catinazzo Thomas
Senior Vice President, Finance
Sold, plan not stated
295
$9.76K
1.9%
RLAY Relay Therapeutics, Inc.
27 Dec 2021
Adams Brian
General Counsel
Sold, plan not stated
295
$9.76K
1.2%
RLAY Relay Therapeutics, Inc.
27 Dec 2021
Porter Andy
See Remarks
Sold, plan not stated
260
$8.61K
1.1%
RLAY Relay Therapeutics, Inc.
15 Nov 2021
Catinazzo Thomas
Senior Vice President, Finance
Sold, plan not stated
22,500
$796.50K
59.5%
RLAY Relay Therapeutics, Inc.
15 Nov 2021
Adams Brian
General Counsel
Sold, plan not stated
6,500
$230.23K
20.5%
RLAY Relay Therapeutics, Inc.
15 Oct 2021
Bergstrom Donald A
See Remarks
Sold, plan not stated
30,000
$1.02M
39.7%
RLAY Relay Therapeutics, Inc.
27 Sep 2021
Bergstrom Donald A
See Remarks
Sold, plan not stated
646
$23.82K
0.8%
RLAY Relay Therapeutics, Inc.
27 Sep 2021
Catinazzo Thomas
Senior Vice President, Finance
Sold, plan not stated
293
$10.80K
1.9%
RLAY Relay Therapeutics, Inc.
27 Sep 2021
Adams Brian
General Counsel
Sold, plan not stated
293
$10.80K
1.1%
RLAY Relay Therapeutics, Inc.
13 Sep 2021
Catinazzo Thomas
Senior Vice President, Finance
Sold, plan not stated
22,500
$787.50K
59.1%
RLAY Relay Therapeutics, Inc.
13 Sep 2021
Adams Brian
General Counsel
Sold, plan not stated
6,500
$227.63K
20.3%
RLAY Relay Therapeutics, Inc.
28 Jun 2021
Bergstrom Donald A
See Remarks
Sold, plan not stated
976
$34.95K
1.3%
RLAY Relay Therapeutics, Inc.
28 Jun 2021
Adams Brian
General Counsel
Sold, plan not stated
293
$10.49K
1.1%
RLAY Relay Therapeutics, Inc.
28 Jun 2021
Catinazzo Thomas
Senior Vice President, Finance
Sold, plan not stated
293
$10.49K
1.8%
RLAY Relay Therapeutics, Inc.
16 Jun 2021
Bergstrom Donald A
See Remarks
Sold, plan not stated
42,242
$1.43M
35.4%
RLAY Relay Therapeutics, Inc.
7 Jun 2021
Catinazzo Thomas
Senior Vice President, Finance
Sold, plan not stated
22,500
$787.50K
58.6%
RLAY Relay Therapeutics, Inc.
7 Jun 2021
Adams Brian
General Counsel
Sold, plan not stated
6,500
$227.50K
20.1%
RLAY Relay Therapeutics, Inc.
26 Apr 2021
Adams Brian
General Counsel
Sold, plan not stated
6,500
$227.50K
20.1%
RLAY Relay Therapeutics, Inc.
16 Apr 2021
Bergstrom Donald A
See Remarks
Sold, plan not stated
56,324
$1.82M
42.2%
RLAY Relay Therapeutics, Inc.
30 Mar 2021
Catinazzo Thomas
Senior Vice President, Finance
Sold, plan not stated
22,500
$787.50K
100%
RLAY Relay Therapeutics, Inc.
28 Jan 2021
Adams Brian
General Counsel
Sold, plan not stated
5,000
$275.25K
33.3%
RLAY Relay Therapeutics, Inc.
14 Jan 2021
Third Rock Ventures III, L.P.
10% owner indirect
Sold, plan not stated
1,965,294
$80.58M
100%
RLAY Relay Therapeutics, Inc.
13 Jan 2021
Third Rock Ventures III, L.P.
10% owner
Sold, plan not stated 5×
1,311,197
$52.61M
14.5%
RLAY Relay Therapeutics, Inc.
13 Jan 2021
Third Rock Ventures III, L.P.
10% owner indirect
Sold, plan not stated 5×
845,903
$33.94M
30.1%
RLAY Relay Therapeutics, Inc.
12 Jan 2021
Third Rock Ventures III, L.P.
10% owner
Sold, plan not stated
1,500,000
$60.00M
14.2%
RLAY Relay Therapeutics, Inc.
20 Jul 2020
Patel Sanjiv
President and CEO
Bought
25,000
$500.00K
6.6%
RLAY Relay Therapeutics, Inc.
20 Jul 2020
Murcko Mark
Director
Bought
25,000
$500.00K
2.5%
RLAY Relay Therapeutics, Inc.
20 Jul 2020
Rubin Jami
Director
Bought
25,000
$500.00K
opened
RLAY Relay Therapeutics, Inc.
20 Jul 2020
INGRAM DOUGLAS S
Director
Bought
25,000
$500.00K
opened
RLAY Relay Therapeutics, Inc.
20 Jul 2020
Adams Brian
General Counsel
Bought
10,000
$200.00K
opened
Showing 201–244 of 244. ← Newer Page 5 of 5